Patients with Discordant Responses to Antiretroviral Therapy Have Impaired Killing of HIV-Infected T Cells

Open Access

Peer-reviewed

Research Article

Sekar Natesampillai,

Affiliation Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Zilin Nie,

Affiliation University of Michigan, Ann Arbor, Michigan, United States of America
⨯
Nathan W. Cummins,

Affiliation Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Dirk Jochmans,

Affiliation Tibotec BVBA, Mechelen, Belgium
⨯
Gary D. Bren,

Affiliation Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Jonathan B. Angel,

Affiliation Immunodeficiency Clinic, Ottawa Hospital, Ottawa, Ontario, Canada
⨯
Andrew D. Badley

* E-mail: badley.andrew@mayo.edu

Affiliation Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America
⨯

Reader Comments (0)

Proteases
Is the Subject Area "Proteases" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
T helper cells
Is the Subject Area "T helper cells" applicable to this article?

Thanks for your feedback.
Yellow fluorescent protein
Is the Subject Area "Yellow fluorescent protein" applicable to this article?

Thanks for your feedback.
HIV infections
Is the Subject Area "HIV infections" applicable to this article?

Thanks for your feedback.
Point mutation
Is the Subject Area "Point mutation" applicable to this article?

Thanks for your feedback.
Cell death
Is the Subject Area "Cell death" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.